Evogene (EVGN) — Capital Reinvestment Ratio
Latest as of December 2012:
2.78x
Evogene (EVGN) has a Capital Reinvestment Ratio of 2.78x as of December 2012, meaning it reinvests 3% of its operating cash flow (ILA100.00K) in capital expenditures (ILA278.00K). Check Evogene tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
2.78x
Capex / Operating Cash Flow
Operating Cash Flow
ILA100.00K
ILA
Capital Expenditures
ILA278.00K
ILA
Data as of
Dec 2012
Most recent filing
Evogene Capital Reinvestment Ratio (2008–2011)
This chart tracks Evogene's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Evogene operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Evogene (2008–2011)
Year-by-year Capital Reinvestment Ratio for Evogene from 2008 to 2011. See Evogene free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 1.76x | ILA2.13 Million | ILA3.76 Million | ▼ -39.6% |
| 2009 | 2.92x | ILA886.00K | ILA2.59 Million | ▲ +3934.4% |
| 2008 | 0.07x | ILA12.61 Million | ILA912.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow